Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence.

TitleUncoupling of mTORC1 from E2F activity maintains DNA damage and senescence.
Publication TypeJournal Article
Year of Publication2024
AuthorsDaigh LH, Saha D, Rosenthal DL, Ferrick KR, Meyer T
JournalNat Commun
Volume15
Issue1
Pagination9181
Date Published2024 Oct 24
ISSN2041-1723
KeywordsAnimals, Cellular Senescence, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase Inhibitor p16, DNA Damage, DNA Repair, DNA Replication, E2F Transcription Factors, Humans, Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Single-Cell Analysis
Abstract

DNA damage is a primary trigger for cellular senescence, which in turn causes organismal aging and is a promising target of anti-aging therapies. Most DNA damage occurs when DNA is fragile during DNA replication in S phase, but senescent cells maintain DNA damage long-after DNA replication has stopped. How senescent cells induce DNA damage and why senescent cells fail to repair damaged DNA remain open questions. Here, we combine reversible expression of the senescence-inducing CDK4/6 inhibitory protein p16INK4 (p16) with live single-cell analysis and show that sustained mTORC1 signaling triggers senescence in non-proliferating cells by increasing transcriptional DNA damage and inflammation signaling that persists after p16 is degraded. Strikingly, we show that activation of E2F transcriptional program, which is regulated by CDK4/6 activity and promotes expression of DNA repair proteins, repairs transcriptionally damaged DNA without requiring DNA replication. Together, our study suggests that senescence can be maintained by ongoing mTORC1-induced transcriptional DNA damage that cannot be sufficiently repaired without induction of protective E2F target genes.

DOI10.1038/s41467-024-52820-6
Alternate JournalNat Commun
PubMed ID39448567
PubMed Central IDPMC11502682
Grant ListR35 GM12702601 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) /

Person Type: